OMNIBLEND INNOVATION PTY LTD has a total of 39 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2013. It filed its patents most often in Australia, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, foods and drinks and computer technology are ZHOU XIANGHUI, ANHUI QUANKANG PHARMACEUTICAL CO LTD and GUANGZHOU ZHENGGUANG BIOLOGICAL TECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 7 | |
#2 | United States | 6 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | WIPO (World Intellectual Property Organization) | 5 | |
#5 | Canada | 4 | |
#6 | Israel | 4 | |
#7 | China | 3 | |
#8 | Hong Kong | 3 | |
#9 | New Zealand | 1 | |
#10 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Computer technology | |
#4 | Medical technology | |
#5 | Packaging and shipping | |
#6 | Machines | |
#7 | IT methods for management |
# | Name | Total Patents |
---|---|---|
#1 | Lichti Gottfried | 38 |
#2 | Lichti Christopher Walter | 29 |
#3 | Best Peter Richard Wynter | 10 |
#4 | Best Janena Frances | 10 |
#5 | Nudel Arie | 9 |
#6 | Peter Richard Wynter Best | 1 |
#7 | Janena Frances Best | 1 |
#8 | Christopher Walter Lichti | 1 |
#9 | Gottfried Lichti | 1 |
Publication | Filing date | Title |
---|---|---|
AU2016250911A1 | Pharmaceutical powder composition and its use in the control of post-prandial glycaemic profile | |
AU2014366886A1 | Method and system for verifying of the authenticity of a consumer product | |
CA2930920A1 | Regimen and method for treatment of type 2 diabetes | |
CN106028841A | Composition and method for control of post-prandial glucose | |
AU2013204801B2 | Composition and method for management of diabetes or pre-diabetes |